ERBB2 and breast cancer: PKCα was also reported to have a role in recycling Her2 to the cell surface in Her2-overexpressing but unamplified breast cancer cells; whereas reducing PKCα by 50% via siRNA resulted in a 40% reduction of total Her2 [31].